Rządowy projekt ustawy o zmianie ustawy o substancjach i preparatach chemicznych oraz niektórych innych ustaw

1
2
3
4
5
6
7
8
613-200-00-3
produkt reakcji: miedź, kwas
420-980-7
-
Xi; R41
(29H ,31H -ftalocyjaniano(2-)-
Xi
-N 29,N 30,N 31,N 32)chlorosiarkowy(VI)
R: 41
i 3-(2-sulfooksyetylosulfonylo)anilina
S: (2-)22-26-39
- sole sodowe
613-201-00-9
(R )-5-bromo-3-(1-metylopirolidyn-
422-390-5
143322-57-0
Repro. Kat. 3; R62
-2-ylometylo)-1H -indol
T; R39-48/25
T; N
Xn; R20/22
R: 20/22-39-41-43-48/25-62-50/53
Xi; R41
S: (1/2-)53-45-60-61
R43
N; R50-53
613-202-00-4
pimetrozyna;
-
123312-89-0
Rakotw. Kat. 3; R40
(E )-4,5-dihydro-6-metylo-4-(3-pirydylo-
R52-53
Xn
metylenoamino)-1,2,4-triazyn-3(2H )-on
R: 40-52/53
S: (2-)36/37-61
613-203-00-X
piraflufen etylowy (PN) [1],
- [1]
129630-19-9 [1] N; R50-53
piraflufen (PN) [2];
- [2]
129630-17-7 [2]
N
kwas 2-chloro-5-(4-chloro-5-difluoro-
R: 50/53
metoksy-1-metylopirazol-3-ilo)-
S: 60-61
-4-fluorofenoksyoctowy [2]
613-204-00-5
oksadiargil (PN);
254-637-6
39807-15-3
Repro. Kat. 3; R63
3-[2,4-dichloro-5-(2-propynyloksy)fenylo]-
Xn; R48/22
Xn; N
-5-(1,1-dimetyloetylo)-1,3,4-oksadiazol-
N; R50-53
R: 48/22-63-50/53
-2(3H )-on;
S: (2-)36/37-46-60-61
5-tert -butylo-3-[2,4-dichloro-
-5-(prop-2-ynyloksy)fenylo]-
-3H -1,3,4-oksadiazol-2-on
613-205-00-0
propikonazol (PN);
262-104-4
60207-90-1
Xn; R22
(RS )-1-[2-(2,4-dichlorofenylo)-4-propylo-
R43
Xn; N
-1,3-dioksolan-2-ylometylo]-
N; R50-53
R: 22-43-50/53
-1H -1,2,4-triazol;
S: (2-)36/37-46-60-61
(+)-1-[2-(2,4-dichlorofenylo)-4-propylo-
-1,3-dioksolan-2-ylometylo]-
-1H -1,2,4-triazol
613-206-00-6
fenamidon (PN);
-
161326-34-7
N; R50-53
(S )-5-fenylo-3-fenyloamino-5-metylo-
N
-2-metylotio-3,5-dihydroimidazol-4-on;
R: 50/53
(S )-1-anilino-4-fenylo-4-metylo-
S: 60-61
-2-metylotioimidazolin-5-on
613-207-00-1
wodorosiarczan(VI) imazalilu (PN) -
261-351-5
58594-72-2
Xn; R22
- roztwór wodny;
281-291-3
83918-57-4
C; R34
C; N
C>50%
C; Xn; N; R22-34-43-50/53
wodorosiarczan(VI) 1-[2-alliloksy-
R43
R: 22-34-43-50/53
30%<C≤50%
Xn; N; R22-38-41-43-50/53
-2-(2,4-dichlorofenylo)etylo]-
N; R50-53
S: (2-)26-36/37/39-45-60-61
25%≤C≤30%
Xn; N; R22-41-43-50/53
-1H -imidazolium;
15%<C<25%
Xi; N; R41-43-51/53
wodorosiarczan(VI) 1-( -alliloksy-
5%≤C≤15%
Xi; N; R36-43-51/53
-2,4-dichlorofenetylo)imidazolium;
2,5%≤C<5%
Xi; N; R43-51/53
wodorosiarczan(VI) (+/-)-1-[2-alliloksy-
1%≤C<2,5%
Xi; R43-52/53
-2-(2,4-dichlorofenylo)etylo]-
0,25%≤C<1%

-1H -imidazolium
613-208-00-7
imazamoks (PN);
-
114311-32-9
N; R50-53
kwas 2-(4-izopropylo-4-metylo-5-okso-
N
-4,5-dihydro-1H -imidazol-2-ilo)-
R: 50/53
-5-metoksymetylonikotynowy
S: 60-61
613-209-00-2
chlorowodorek cis -1-(3-chloropropylo)-
417-430-3
63645-17-0
T; R25
-2,6-dimetylopiperydyny
Xn; R48/22
T; N
R43
R: 25-43-48/22-51/53
N; R51-53
S: (1/2-)22-36/37-45-61
Tabela A
Strona 194 z 265
1
2
3
4
5
6
7
8
613-210-00-8
2-(3-chloropropylo)-2,5,5-trimetylo-
417-650-1
88128-57-8
Xn; R48/22
-1,3-dioksan
R52-53
Xn
R: 48/22-52/53
S: (2-)23-25-36-61
613-211-00-3
metylosiarczan(VI) N -metylo-
418-240-3
74401-04-0
R43
-4-(p -formylostyrylo)pirydynium
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61
613-212-00-9
1,1-tlenek 4-[4-(2-etyloheksyloksy)fenylo]-
418-320-8
133467-41-1
Xn; R22
-1,4-tiazinanu
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61
613-213-00-4
cis -1-benzoilo-4-[(4-metylosulfonylo)-
416-040-0
120807-02-5
R52-53
oksy]-L-prolina
R: 52/53
S: 61
613-214-00-X
N,N -dibutylo-2-(1,2-dihydro-3-hydroksy-
416-260-7
147613-95-4
R53
-6-izopropylochinolin-2-ylideno)-
-1,3-dioksoindano-5-karboksyamid
R: 53
S: 61
613-215-00-5
chlorek 2-chlorometylo-3,4-dimetoksy-
416-440-5
72830-09-2
Xn; R21/22-48/22
pirydynium
Xi; R38-41
Xn; N
R43
R: 21/22-38-41-43-48/22-51/53
N; R51-53
S: (2-)26-36/37/39-61
613-216-00-0
6-tert -butylo-7-(6-dietyloamino-2-metylo-
416-490-8
-
N; R50-53
-3-pirydyloimino)-3-(3-metylofenylo)-
N
pirazolo[3,2-c ][1,2,4]triazol
R: 50/53
S: 60-61
613-217-00-6
4-[3-(3,5-di-tert -butylo-4-hydroksyfenylo)-
416-770-1
73754-27-5
R53
propanoiloksy]-1-{2-[3-(3,5-di-tert -butylo-
-4-hydroksyfenylo)propanoiloksy]etylo}-
R: 53
-2,2,6,6-tetrametylopiperydyna
S: 61
613-218-00-1
6-hydroksyindol
417-020-4
2380-86-1
Xn; R22
Xi; R41
Xn; N
R43
R: 22-41-43-51/53
N; R51-53
S: (2-)24-26-37/39-61
613-219-00-7
7a-etylo-3,5-bis(1-metyloetylo)-
417-140-7
79185-77-6
Xi; R38
-2,3,4,5-tetrahydrooksazolo-
N; R51-53
Xi; N
[3,4-c ]-2,3,4,5-tetrahydrooksazol
R: 38-51/53
S: (2-)37-61
613-220-00-2
7,7-ditlenek trans -(4S ,6S )-6-metylo-
417-290-3
147086-81-5
Xn; R22
-5,6-dihydro-4H -tieno[2,3-b ]tiopiran-4-olu
Xn
R: 22
S: (2-)36
613-221-00-8
2-chloro-5-metylopirydyna
418-050-0
18368-64-4
Xn; R21/22
Xi; R38
Xn
R52-53
R: 21/22-38-52/53
S: (2-)23-25-36/37-61
613-222-00-3
4-(1-oksoprop-2-enylo)morfolina;
418-140-1
5117-12-4
Xn; R22-48/22
N -akryloilomorfolina
Xi; R41
Xn
R43
R: 22-41-43-48/22
S: (2-)23-26-36/37/39
613-223-00-9
N -izopropylo-3-(4-fluorofenylo)-1H -indol
418-790-4
93957-49-4
R53
R: 53
S: 61
613-224-00-4
2,5-disulfanylometylo-1,4-ditian;
419-770-8
136122-15-1
Xn; R22
2,5-dimerkaptometylo-1,4-ditian
C; R34
C; N
R43
R: 22-34-43-50/53
N; R50-53
S: (1/2-)26-36/37/39-45-60-61
Tabela A
Strona 195 z 265
1
2
3
4
5
6
7
8
613-225-00-X
mieszanina:
421-290-9
-
Xn; R48/22
2-(antrachinon-1-yloamino)-
R53
Xn
-6-[(5-benzoiloamino)antrachinon-
R: 48/22-53
-1-yloamino]-4-fenylo-1,3,5-triazyna,
S: (2-)22-36-61
2,6-bis[(5-benzoiloamino)antrachinon-
-1-yloamino]-4-fenylo-1,3,5-triazyna
613-226-00-5
dichlorek 1-[2-(etylo{4-[4-(4-{4-[etylo-
420-950-3
163831-67-2
Xi; R41
(2-pirydynyloetylo)amino]-2-metylofenylo-
N; R50-53
Xi; N
azo}benzoiloamino)fenyloazo]-3-metylo-
R: 41-50/53
fenylo}amino)etylo]pirydynium
S: (2-)26-39-60-61
613-227-00-0
(+/-)-[(R *,R *) i (R *,S *)]-6-fluoro-3,4-di-
419-600-2
-
R43
hydrooksiran-2-ylo-2H -1-benzopiran
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-28-36/37-61
613-228-00-6
(+/-)-(R *,S *)-6-fluoro-3,4-dihydro-
419-630-6
-
N; R51-53
oksiran-2-ylo-2H -1-benzopiran
N
R: 51/53
S: 24-61
613-230-00-7
florasulam (PN);
-
145701-23-1
N; R50-53
2',6',8-trifluoro-5-metoksy-5-triazolo-
N
[1,5-c ]pirymidyno-2-sulfonoanilid
R: 50/53
S: 60-61
613-233-00-3
4,4'-[oksy(bismetyleno)]bis-
423-230-7
56552-15-9
Xi; R41
-1,3-dioksolan
Xi
R: 41
S: (2-)26-39
614-001-00-4
nikotyna;
200-193-3
54-11-5
T+; R27
3-(N -metylopirolidyn-2-ylo)pirydyna
T; R25
T+; N
N; R51-53
R: 25-27-51/53
S: (1/2-)36/37-45-61
614-002-00-X
sole nikotyny
-
-
T+; R26/27/28
NOTA A
(3-(N -metylo-2-pirolidynylo)pirydyny)
N; R51-53
T+; N
R: 26/27/28-51/53
S: (1/2-)13-28-45-61
614-003-00-5
strychnina
200-319-7
57-24-9
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)36/37-45-60-61
614-004-00-0
sole strychniny
-
-
T+; R26/28
NOTA A
N; R50-53
T+; N
R: 26/28-50/53
S: (1/2-)13-28-45-60-61
614-005-00-6
kolchicyna
200-598-5
64-86-8
T+; R26/28
T+
R: 26/28
S: (1/2-)13-45
614-006-00-1
brucyna;
206-614-7
357-57-3
T+; R26/28
2,3-dimetoksystrychnina
R52-53
T+
R: 26/28-52/53
S: (1/2-)13-45-61
614-007-00-7
siarczan(VI) brucyny [1],
225-432-9 [1] 4845-99-2 [1]
T+; R26/28
azotan(V) brucyny [2],
227-317-9 [2] 5786-97-0 [2]
R52-53
T+
2,3-dimetoksystrychnidyn-10-on,
269-439-5 [3] 68239-26-9 [3]
R: 26/28-52/53
związek z benzeno-1,2-dikarboksylanem
269-710-8 [4] 68310-42-9 [4]
S: (1/2-)13-45-61
(R )-mono(1-metyloheptylu) [3];
2,3-dimetoksystrychnidyn-10-on,
związek z benzeno-1,2-dikarboksylanem
(S )-mono(1-metyloheptylu) (1:1) [4]
Tabela A
Strona 196 z 265
1
2
3
4
5
6
7
8
614-008-00-2
akonityna
206-121-7
302-27-2
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45
614-009-00-8
sole akonityny
-
-
T+; R26/28
NOTA A
T+
R: 26/28
S: (1/2-)24-45
614-010-00-3
atropina
200-104-8
51-55-8
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45
614-011-00-9
sole atropiny
-
-
T+; R26/28
NOTA A
T+
R: 26/28
S: (1/2-)25-45
614-012-00-4
hioscyjamina
202-933-0
101-31-5
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45
614-013-00-X
sole hioscyjaminy
-
-
T+; R26/28
NOTA A
T+
R: 26/28
S: (1/2-)24-45
614-014-00-5
skopolamina
200-090-3
51-34-3
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)25-45
614-015-00-0
sole skopolaminy
-
-
T+; R26/27/28
NOTA A
T+
R: 26/27/28
S: (1/2-)25-45
614-016-00-6
pilokarpina
202-128-4
92-13-7
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45
614-017-00-1
sole pilokarpiny
-
-
T+; R26/28
NOTA A
T+
R: 26/28
S: (1/2-)25-45
614-018-00-7
papaweryna
200-397-2
58-74-2
Xn; R22
Xn
R: 22
S: (2-)22
614-019-00-2
sole papaweryny
-
-
Xn; R22
NOTA A
Xn
R: 22
S: (2-)22
614-020-00-8
fizostygmina
200-332-8
57-47-6
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45
614-021-00-3
sole fizostygminy
-
-
T+; R26/28
NOTA A
T+
R: 26/28
S: (1/2-)25-45
614-022-00-9
digitoksyna
200-760-5
71-63-6
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45
Tabela A
Strona 197 z 265
1
2
3
4
5
6
7
8
614-023-00-4
efedryna
206-080-5
299-42-3
Xn; R22
Xn
R: 22
S: (2-)22-25
614-024-00-X
sole efedryny
-
-
Xn; R22
NOTA A
Xn
R: 22
S: (2-)22-25
614-025-00-5
strofantyna-G
211-139-3
630-60-4
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45
614-026-00-0
strofantozyd-K
234-239-9
11005-63-3
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45
614-027-00-6
scillirosan;
208-077-4
507-60-8
T+; R28
6- -acetyloksy-3 -( -D-glukopirano-
T+
siloksy)-8,14-dihydroksy-
R: 28
-bufa-4,20,22-trienolid
S: (1/2-)36/37-45
614-028-00-1
mieszanina:
414-420-0
-
Xi; R41
mono-D-glukopiranozyd 2-etyloheksylu,
Xi
di-D-glukopiranozyd 2-etyloheksylu
R: 41
S: (2-)26-39
614-029-00-7
izomery strukturalne penta-O-allilo- -D-
419-640-0
68784-14-5
Xn; R22
fruktofuranozoilo-α-D-glukopiranozydu,
Xn
izomery strukturalne heksa-O-allilo- -D-
R: 22
fruktofuranozoilo-α-D-glukopiranozydu,
S: (2)
izomery strukturalne hepta-O-allilo- -D-
fruktofuranozoilo-α-D-glukopiranozydu
615-001-00-7
izocyjanian metylu
210-866-3
624-83-9
F+; R12
Repro. Kat. 3; R63
F+; T+
T+; R26
R: 12-24/25-26-37/38-41-42/43-63
T; R24/25
S: (1/2-)26-27/28-36/37/39-45-63
R42/43
Xi; R37/38-41
615-002-00-2
izotiocyjanian metylu
209-132-5
556-61-6
T; R23/25
C; R34
T; N
R43
R: 23/25-34-43-50/53
N; R50-53
S: (1/2-)36/37-38-45-60-61
615-003-00-8
kwas tiocyjanowy;
207-337-4
463-56-9
Xn; R20/21/22
kwas rodanowodorowy
R32
Xn
R52-53
R: 20/21/22-32-52/53
S: (2-)13-61
615-004-00-3
tiocyjaniany
-
-
Xn; R20/21/22
NOTA A
R32
Xn
R52-53
R: 20/21/22-32-52/53
S: (2-)13-61
Tabela A
Strona 198 z 265